CVS CVS HEALTH Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CVS

Price (delayed)

$85.84

Market cap

$113.27B

P/E Ratio

15.69

Dividend/share

$2

EPS

$5.47

Enterprise value

$185.81B

CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. ...

Highlights
The debt has contracted by 13% YoY and by 3.2% from the previous quarter
CVS's equity is up by 8% YoY and by 3.4% QoQ
CVS's quick ratio is down by 8% YoY but it is up by 7% QoQ
CVS's price to earnings (P/E) is 24% higher than its last 4 quarters average of 12.7 and 5% higher than its 5-year quarterly average of 14.9
The net income has declined by 13% year-on-year and by 2.6% since the previous quarter
Sector: Healthcare
Industry: Healthcare Plans
Website: https://cvshealth.com/
Peers: PETS RAD WBA

Key stats

What are the main financial stats of CVS
Market
Shares outstanding
1.32B
Market cap
$113.27B
Enterprise value
$185.81B
Valuations
Price to earnings (P/E)
15.69
Price to book (P/B)
1.54
Price to sales (P/S)
0.41
EV/EBIT
14.96
EV/EBITDA
12.66
EV/Sales
0.67
Earnings
Revenue
$278.32B
EBIT
$12.42B
EBITDA
$14.68B
Free cash flow
$11.62B
Per share
EPS
$5.47
Free cash flow per share
$8.81
Book value per share
$55.63
Revenue per share
$211.01
TBVPS
$92.14
Balance sheet
Total assets
$231.16B
Total liabilities
$157.6B
Debt
$79.65B
Equity
$73.24B
Working capital
-$2.75B
Liquidity
Debt to equity
1.09
Current ratio
0.95
Quick ratio
0.58
Net debt/EBITDA
4.94
Margins
EBITDA margin
5.3%
Gross margin
17.7%
Net margin
2.6%
Operating margin
4.9%
Efficiency
Return on assets
3.1%
Return on equity
10.2%
Return on invested capital
9.1%
Return on capital employed
7.2%
Return on sales
4.5%
Dividend
Dividend yield
2.33%
DPS
$2
Payout ratio
36.6%

CVS stock price

How has the CVS HEALTH stock price performed over time
Intraday
1.51%
1 week
1.74%
1 month
0.35%
1 year
44.71%
YTD
25.68%
QTD
1.15%

Financial performance

How have CVS HEALTH's revenue and profit performed over time
Revenue
$278.32B
Gross profit
$49.37B
Operating income
$13.68B
Net income
$7.2B
Gross margin
17.7%
Net margin
2.6%
The net margin has contracted by 16% YoY and by 3.7% from the previous quarter
The net income has declined by 13% year-on-year and by 2.6% since the previous quarter
The company's operating margin fell by 8% YoY and by 6% QoQ
The revenue has grown by 6% YoY and by 2.7% from the previous quarter

Growth

What is CVS HEALTH's growth rate over time

Valuation

What is CVS HEALTH stock price valuation
P/E
15.69
P/B
1.54
P/S
0.41
EV/EBIT
14.96
EV/EBITDA
12.66
EV/Sales
0.67
CVS's price to earnings (P/E) is 24% higher than its last 4 quarters average of 12.7 and 5% higher than its 5-year quarterly average of 14.9
CVS HEALTH's EPS has decreased by 13% YoY and by 2.8% QoQ
CVS's price to book (P/B) is 18% more than its last 4 quarters average of 1.3 but 3.8% less than its 5-year quarterly average of 1.6
CVS's equity is up by 8% YoY and by 3.4% QoQ
The stock's price to sales (P/S) is 37% more than its last 4 quarters average of 0.3 and 2.5% more than its 5-year quarterly average of 0.4
The revenue has grown by 6% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is CVS HEALTH business performance
CVS's ROE is down by 20% YoY and by 4.7% QoQ
CVS HEALTH's return on sales has decreased by 17% YoY and by 4.3% QoQ
The return on assets has declined by 14% year-on-year and by 3.1% since the previous quarter
CVS HEALTH's return on invested capital has decreased by 11% YoY and by 3.2% QoQ

Dividends

What is CVS's dividend history
Dividend details
DPS
$2
Dividend yield
2.33%
Payout ratio
36.6%
Recent dividends

Financial health

How did CVS HEALTH financials performed over time
CVS HEALTH's total assets is 47% more than its total liabilities
CVS's quick ratio is down by 8% YoY but it is up by 7% QoQ
The company's total liabilities fell by 6% YoY
The debt is 9% more than the equity
CVS HEALTH's debt to equity has decreased by 19% YoY and by 6% QoQ
The debt has contracted by 13% YoY and by 3.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.